These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Delays between Uveal Melanoma Diagnosis and Treatment Increase the Risk of Metastatic Death. Stålhammar G Ophthalmology; 2024 Sep; 131(9):1094-1104. PubMed ID: 37995852 [TBL] [Abstract][Full Text] [Related]
26. Isolated hepatic perfusion for ocular melanoma metastasis: registry data suggests a survival benefit. Olofsson R; Cahlin C; All-Ericsson C; Hashimi F; Mattsson J; Rizell M; Lindnér P Ann Surg Oncol; 2014 Feb; 21(2):466-72. PubMed ID: 24141377 [TBL] [Abstract][Full Text] [Related]
27. Time to systemic metastases in patients with posterior uveal melanoma. Sato T; Babazono A; Shields JA; Shields CL; De Potter P; Mastrangelo MJ Cancer Invest; 1997; 15(2):98-105. PubMed ID: 9095204 [TBL] [Abstract][Full Text] [Related]
28. Prognoses and Clinical Outcomes of Primary and Recurrent Uveal Melanoma. Kim JH; Shin SJ; Heo SJ; Choe EA; Kim CG; Jung M; Keum KC; Yoon JS; Lee SC; Shin SJ Cancer Res Treat; 2018 Oct; 50(4):1238-1251. PubMed ID: 29281872 [TBL] [Abstract][Full Text] [Related]
32. Evolutionary Routes in Metastatic Uveal Melanomas Depend on Rodrigues M; Mobuchon L; Houy A; Alsafadi S; Baulande S; Mariani O; Marande B; Ait Rais K; Van der Kooij MK; Kapiteijn E; Gassama S; Gardrat S; Barnhill RL; Servois V; Dendale R; Putterman M; Tick S; Piperno-Neumann S; Cassoux N; Pierron G; Waterfall JJ; Roman-Roman S; Mariani P; Stern MH Clin Cancer Res; 2019 Sep; 25(18):5513-5524. PubMed ID: 31227496 [TBL] [Abstract][Full Text] [Related]
33. Clinical Features, Metastasis, and Survival in Patients Younger Than 21 Years With Posterior Uveal Melanoma. Fry MV; Augsburger JJ; Corrêa ZM JAMA Ophthalmol; 2019 Jan; 137(1):75-81. PubMed ID: 30422230 [TBL] [Abstract][Full Text] [Related]
34. A multireferral centre retrospective cohort analysis on the experience in treatment of metastatic uveal melanoma and utilization of sequential liver-directed treatment and immunotherapy. Itchins M; Ascierto PA; Menzies AM; Oatley M; Lo S; Douraghi-Zadeh D; Harrington T; Maher R; Grimaldi AM; Guminski A Melanoma Res; 2017 Jun; 27(3):243-250. PubMed ID: 28230715 [TBL] [Abstract][Full Text] [Related]
35. A pilot study of intrahepatic yttrium-90 microsphere radioembolization in combination with intravenous cisplatin for uveal melanoma liver-only metastases. Arulananda S; Parakh S; Palmer J; Goodwin M; Andrews MC; Cebon J Cancer Rep (Hoboken); 2019 Aug; 2(4):e1183. PubMed ID: 32721131 [TBL] [Abstract][Full Text] [Related]
36. Recent breakthroughs in metastatic uveal melanoma: a cause for optimism? Sacco JJ; Kalirai H; Kenyani J; Figueiredo CR; Coulson JM; Coupland SE Future Oncol; 2018 Jun; 14(14):1335-1338. PubMed ID: 29741103 [No Abstract] [Full Text] [Related]
37. Local Recurrence Significantly Increases the Risk of Metastatic Uveal Melanoma. Ophthalmic Oncology Task Force Ophthalmology; 2016 Jan; 123(1):86-91. PubMed ID: 26505803 [TBL] [Abstract][Full Text] [Related]
38. Prognostic factors for first-line therapy and overall survival of metastatic uveal melanoma: The Princess Margaret Cancer Centre experience. Nicholas MN; Khoja L; Atenafu EG; Hogg D; Quirt I; Butler M; Joshua AM Melanoma Res; 2018 Dec; 28(6):571-577. PubMed ID: 30067547 [TBL] [Abstract][Full Text] [Related]
39. New NCCN Guidelines for Uveal Melanoma and Treatment of Recurrent or Progressive Distant Metastatic Melanoma. Barker CA; Salama AK J Natl Compr Canc Netw; 2018 May; 16(5S):646-650. PubMed ID: 29784747 [TBL] [Abstract][Full Text] [Related]